{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Ras/Raf/MER/ERK", "STAT3/c-Myc", "apoptosis", "dianilinopyrimidines", "leukemia"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38611876", "DateCompleted": {"Year": "2024", "Month": "04", "Day": "15"}, "DateRevised": {"Year": "2024", "Month": "04", "Day": "25"}, "Article": {"Language": ["eng"], "ELocationID": ["1597", "10.3390/molecules29071597"], "ArticleDate": [{"Year": "2024", "Month": "04", "Day": "03"}], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "29", "Issue": "7", "PubDate": {"Year": "2024", "Month": "Apr", "Day": "03"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Design, Synthesis, and Anti-Leukemic Evaluation of a Series of Dianilinopyrimidines by Regulating the Ras/Raf/MEK/ERK and STAT3/c-Myc Pathways.", "Abstract": {"AbstractText": ["Although the long-term survival rate for leukemia has made significant progress over the years with the development of chemotherapeutics, patients still suffer from relapse, leading to an unsatisfactory outcome. To discover the new effective anti-leukemia compounds, we synthesized a series of dianilinopyrimidines and evaluated the anti-leukemia activities of those compounds by using leukemia cell lines (HEL, Jurkat, and K562). The results showed that the dianilinopyrimidine analog <b>H-120</b> predominantly displayed the highest cytotoxic potential in HEL cells. It remarkably induced apoptosis of HEL cells by activating the apoptosis-related proteins (cleaved caspase-3, cleaved caspase-9 and cleaved poly ADP-ribose polymerase (PARP)), increasing apoptosis protein Bad expression, and decreasing the expression of anti-apoptotic proteins (Bcl-2 and Bcl-xL). Furthermore, it induced cell cycle arrest in G2/M; concomitantly, we observed the activation of p53 and a reduction in phosphorylated cell division cycle 25C (p-CDC25C) / Cyclin B1 levels in treated cells. Additionally, the mechanism study revealed that <b>H-120</b> decreased these phosphorylated signal transducers and activators of transcription 3, rat sarcoma, phosphorylated cellular RAF proto-oncogene serine / threonine kinase, phosphorylated mitogen-activated protein kinase kinase, phosphorylated extracellular signal-regulated kinase, and cellular myelocytomatosis oncogene (p-STAT3, Ras, p-C-Raf, p-MEK, p-MRK, and c-Myc) protein levels in HEL cells. Using the cytoplasmic and nuclear proteins isolation assay, we found for the first time that <b>H-120</b> can inhibit the activation of STAT3 and c-Myc and block STAT3 phosphorylation and dimerization. Moreover, <b>H-120</b> treatment effectively inhibited the disease progression of erythroleukemia mice by promoting erythroid differentiation into the maturation of erythrocytes and activating the immune cells. Significantly, <b>H-120</b> also improved liver function in erythroleukemia mice. Therefore, <b>H-120</b> may be a potential chemotherapeutic drug for leukemia patients."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "College of Pharmacy, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Wang", "ForeName": "Chaoyan", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "College of Basic Medical, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Wang", "ForeName": "Bo", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "College of Pharmacy, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Mou", "ForeName": "Yu", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "College of Basic Medical, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Liu", "ForeName": "Xiang", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "College of Pharmacy, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Chen", "ForeName": "Qiqing", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "College of Pharmacy, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Pu", "ForeName": "Weidong", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province, Guiyang 550014, China."}], "LastName": "Rao", "ForeName": "Qing", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province, Guiyang 550014, China."}], "LastName": "Wang", "ForeName": "Chunlin", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province, Guiyang 550014, China."}], "LastName": "Song", "ForeName": "Jingrui", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province, Guiyang 550014, China."}], "LastName": "Huang", "ForeName": "Yubing", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou University, Guiyang 550000, China."}], "LastName": "Yan", "ForeName": "Longjia", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province, Guiyang 550014, China."}], "LastName": "Huang", "ForeName": "Lei", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province, Guiyang 550014, China."}], "LastName": "Li", "ForeName": "Yanmei", "Initials": "Y"}], "GrantList": [{"GrantID": "82360035, 81960546, 81872772, 82260040, 82160808 and 82060738", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "QKHPTRC [2020]5008, QKHZC [2020]4Y203, QKHJC-ZK[2021]YB569, QKHJC-ZK[2022]YB293, QKHJC-ZK[2023]YB240", "Agency": "the Guizhou Provincial Natural Science Foundation", "Country": ""}, {"GrantID": "RN21025 and RN21024", "Agency": "the Guizhou Medical University Research Grant", "Country": ""}, {"GrantID": "FAMP202005K", "Agency": "the State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University", "Country": ""}, {"GrantID": "QKHRCPT [2019]5106", "Agency": "Guizhou Science and Technology Platform Talents", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "EC 2.7.12.2", "NameOfSubstance": "Mitogen-Activated Protein Kinase Kinases"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Protein Serine-Threonine Kinases"}, {"RegistryNumber": "0", "NameOfSubstance": "STAT3 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "STAT3 Transcription Factor"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mitogen-Activated Protein Kinase Kinases"}, {"QualifierName": [], "DescriptorName": "Leukemia, Erythroblastic, Acute"}, {"QualifierName": [], "DescriptorName": "Phosphorylation"}, {"QualifierName": [], "DescriptorName": "Dimerization"}, {"QualifierName": [], "DescriptorName": "Leukemia"}, {"QualifierName": [], "DescriptorName": "Protein Serine-Threonine Kinases"}, {"QualifierName": [], "DescriptorName": "STAT3 Transcription Factor"}], "CoiStatement": "The authors report no conflicts of interest in this work."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Di Genua C., Valletta S., Buono M., Stoilova B., Sweeney C., Rodriguez-Meira A., Grover A., Drissen R., Meng Y., Beveridge R., et al. C/EBP\u03b1 and GATA-2 Mutations Induce Bilineage Acute Erythroid Leukemia through Transformation of a Neomorphic Neutrophil-Erythroid Progenitor. Cancer Cell. 2020;37:690\u2013704.e8. doi: 10.1016/j.ccell.2020.03.022.", "ArticleIdList": ["10.1016/j.ccell.2020.03.022", "PMC7218711", "32330454"]}, {"Citation": "Liao Z., Li J., Wu J., Liu J., Sun S. Chemotherapeutics for Acute Erythroid Leukemia: Research, Present and Future. CMM. 2021;21:819\u2013831. doi: 10.2174/1566524021666210121142316.", "ArticleIdList": ["10.2174/1566524021666210121142316", "33475071"]}, {"Citation": "Santos F.P., Bueso-Ramos C.E., Ravandi F. Acute Erythroleukemia: Diagnosis and Management. Expert Rev. Hemotol. 2010;3:705\u2013718. doi: 10.1586/ehm.10.62.", "ArticleIdList": ["10.1586/ehm.10.62", "21091147"]}, {"Citation": "Tian Z., Yang L., Huang M., Sun C., Chen M., Zhao W., Peng J., Guo G. Antitumor Activity and Mechanism of Action of the Antimicrobial Peptide AMP-17 on Human Leukemia K562 Cells. Molecules. 2022;27:8109. doi: 10.3390/molecules27228109.", "ArticleIdList": ["10.3390/molecules27228109", "PMC9697079", "36432210"]}, {"Citation": "Ma Z.-Q., Pan J.-H., Jing D.-X., Xu C.-Y. Clinical Characteristics and Prognosis of 167 Cases of Acute Erythroleukemia.  [(accessed on 25 October 2023)];Indian J. Hematol. Blood Transfus. 2017 33:56\u201360. doi: 10.1007/s12288-016-0671-1. Available online:  https://www.x-mol.com/paper/1212913860296384529?adv.", "ArticleIdList": ["10.1007/s12288-016-0671-1", "PMC5280856", "28194057"]}, {"Citation": "Xu Q., Li M., Yang M., Yang J., Xie J., Lu X., Wang F., Chen W. \u03b1-Pinene Regulates miR-221 and Induces G2/M Phase Cell Cycle Arrest in Human Hepatocellular Carcinoma Cells. Biosci. Rep. 2018;38:BSR20180980. doi: 10.1042/BSR20180980.", "ArticleIdList": ["10.1042/BSR20180980", "PMC6294613", "30473536"]}, {"Citation": "Weinberg O.K., Arber D.A. Erythroleukemia: An Update. Curr. Oncol. Rep. 2021;23:69. doi: 10.1007/s11912-021-01060-8.", "ArticleIdList": ["10.1007/s11912-021-01060-8", "33876292"]}, {"Citation": "Liu W., Wu Z., Yu Y., Qiao C., Zhu H., Hong M., Zhu Y., Qian S., Chen S., Wu D., et al. Functional Evaluation of KEL as an Oncogenic Gene in the Progression of Acute Erythroleukemia. Oxid. Med. Cell. Longev. 2022;2022:1\u201313. doi: 10.1155/2022/5885342.", "ArticleIdList": ["10.1155/2022/5885342", "PMC8819426", "35140839"]}, {"Citation": "Alexander C. A History and Current Understanding of Acute Erythroid Leukemia. Clin. Lymphoma Myeloma Leuk. 2023;23:583\u2013588. doi: 10.1016/j.clml.2023.04.011.", "ArticleIdList": ["10.1016/j.clml.2023.04.011", "37246017"]}, {"Citation": "Varmeh-Ziaie S., Resnick-Silverman L., Liu W., Padi A., Dastidar J., DaCosta A., Mattia M., Manfredi J.J. DNA Damage-Induced Downregulation of Cdc25C Is Mediated by P53 via Two Independent Mechanisms: One Involves Direct Binding to the cdc25C Promoter. Mol. Cell. 2004;16:725\u2013736. doi: 10.1016/j.molcel.2004.11.002.", "ArticleIdList": ["10.1016/j.molcel.2004.11.002", "15574328"]}, {"Citation": "Steelman L.S., Franklin R.A., Abrams S.L., Chappell W., Kempf C.R., B\u00e4secke J., Stivala F., Donia M., Fagone P., Nicoletti F., et al. Roles of the Ras/Raf/MEK/ERK Pathway in Leukemia Therapy. Leukemia. 2011;25:1080\u20131094. doi: 10.1038/leu.2011.66.", "ArticleIdList": ["10.1038/leu.2011.66", "21494257"]}, {"Citation": "Gonzalez-Hormazabal P., Musleh M., Bustamante M., Stambuk J., Pisano R., Valladares H., Lanzarini E., Chiong H., Rojas J., Suazo J., et al. Polymorphisms in RAS/RAF/MEK/ERK Pathway Are Associated with Gastric Cancer. Genes. 2018;10:20. doi: 10.3390/genes10010020.", "ArticleIdList": ["10.3390/genes10010020", "PMC6356706", "30597917"]}, {"Citation": "Guo Y., Pan W., Liu S., Shen Z., Xu Y., Hu L. ERK/MAPK Signalling Pathway and Tumorigenesis (Review) Exp. Ther. Med. 2020;19:1997\u20132007. doi: 10.3892/etm.2020.8454.", "ArticleIdList": ["10.3892/etm.2020.8454", "PMC7027163", "32104259"]}, {"Citation": "Kanna R., Choudhary G., Ramachandra N., Steidl U., Verma A., Shastri A. STAT3 Inhibition as a Therapeutic Strategy for Leukemia. Leukemia Lymphoma. 2018;59:2068\u20132074. doi: 10.1080/10428194.2017.1397668.", "ArticleIdList": ["10.1080/10428194.2017.1397668", "29164994"]}, {"Citation": "Beebe J.D., Liu J.-Y., Zhang J.-T. Two Decades of Research in Discovery of Anticancer Drugs Targeting STAT3, How Close Are We? Pharmacol. Ther. 2018;191:74\u201391. doi: 10.1016/j.pharmthera.2018.06.006.", "ArticleIdList": ["10.1016/j.pharmthera.2018.06.006", "29933035"]}, {"Citation": "Zhang H., Nguyen-Jackson H., Panopoulos A.D., Li H.S., Murray P.J., Watowich S.S. STAT3 Controls Myeloid Progenitor Growth during Emergency Granulopoiesis. Blood. 2010;116:2462\u20132471. doi: 10.1182/blood-2009-12-259630.", "ArticleIdList": ["10.1182/blood-2009-12-259630", "PMC2953883", "20581311"]}, {"Citation": "Chen C.-C., Sun Y.-T., Chen J.-J., Chang Y.-J. Tumor Necrosis Factor-\u03b1-Induced Cyclooxygenase-2 Expression via Sequential Activation of Ceramide-Dependent Mitogen-Activated Protein Kinases, and I\u03baB Kinase 1/2 in Human Alveolar Epithelial Cells. Mol. Pharmacol. 2001;59:493\u2013500. doi: 10.1124/mol.59.3.493.", "ArticleIdList": ["10.1124/mol.59.3.493", "11179444"]}, {"Citation": "Mohassab A.M., Hassan H.A., Abdelhamid D., Abdel-Aziz M. STAT3 Transcription Factor as Target for Anti-Cancer Therapy. Pharmacol. Rep. 2020;72:1101\u20131124. doi: 10.1007/s43440-020-00156-5.", "ArticleIdList": ["10.1007/s43440-020-00156-5", "32880101"]}, {"Citation": "Huang M.-J., Cheng Y., Liu C.-R., Lin S., Liu H.E. A Small-Molecule c-Myc Inhibitor, 10058-F4, Induces Cell-Cycle Arrest, Apoptosis, and Myeloid Differentiation of Human Acute Myeloid Leukemia. Exp. Hematol. 2006;34:1480\u20131489. doi: 10.1016/j.exphem.2006.06.019.", "ArticleIdList": ["10.1016/j.exphem.2006.06.019", "17046567"]}, {"Citation": "Luo H., Li Q., O\u2019Neal J., Kreisel F., Le Beau M.M., Tomasson M.H. C-Myc Rapidly Induces Acute Myeloid Leukemia in Mice without Evidence of Lymphoma-Associated Antiapoptotic Mutations. Blood. 2005;106:2452\u20132461. doi: 10.1182/blood-2005-02-0734.", "ArticleIdList": ["10.1182/blood-2005-02-0734", "15972450"]}, {"Citation": "M\u00fcller-Tidow C., Steffen B., Cauvet T., Tickenbrock L., Ji P., Diederichs S., Sargin B., K\u00f6hler G., Stelljes M., Puccetti E., et al. Translocation Products in Acute Myeloid Leukemia Activate the Wnt Signaling Pathway in Hematopoietic Cells. Cell. Mol. Biol. 2004;24:2890\u20132904. doi: 10.1128/MCB.24.7.2890-2904.2004.", "ArticleIdList": ["10.1128/MCB.24.7.2890-2904.2004", "PMC371102", "15024077"]}, {"Citation": "Newman D.J., Cragg G.M. Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. J. Nat. Prod. 2020;83:770\u2013803. doi: 10.1021/acs.jnatprod.9b01285.", "ArticleIdList": ["10.1021/acs.jnatprod.9b01285", "32162523"]}, {"Citation": "Liu L., Michowski W., Kolodziejczyk A., Sicinski P. The Cell Cycle in Stem Cell Proliferation, Pluripotency and Differentiation. Nat. Cell Biol. 2019;21:1060\u20131067. doi: 10.1038/s41556-019-0384-4.", "ArticleIdList": ["10.1038/s41556-019-0384-4", "PMC7065707", "31481793"]}, {"Citation": "Zuo Y., Li R., Zhang Y., Bao G., Le Y., Yan L. Design, Synthesis and Antitumor Activity of 5-Trifluoromethylpyrimidine Derivatives as EGFR Inhibitors. J. Enzyme Inhib. Med. Chem. 2022;37:2742\u20132754. doi: 10.1080/14756366.2022.2128797.", "ArticleIdList": ["10.1080/14756366.2022.2128797", "PMC9542405", "36176072"]}, {"Citation": "Yan L., Wang Q., Liu L., Le Y. Design, Synthesis and Biological Evaluation of a Series of Dianilinopyrimidines as EGFR Inhibitors. J. Enzyme Inhib. Med. Chem. 2022;37:832\u2013843. doi: 10.1080/14756366.2022.2046567.", "ArticleIdList": ["10.1080/14756366.2022.2046567", "PMC8920385", "35260020"]}, {"Citation": "Ong S.-B., Kalkhoran S.B., Cabrera-Fuentes H.A., Hausenloy D.J. Mitochondrial Fusion and Fission Proteins as Novel Therapeutic Targets for Treating Cardiovascular Disease. Eur. J. Pharmacol. 2015;763:104\u2013114. doi: 10.1016/j.ejphar.2015.04.056.", "ArticleIdList": ["10.1016/j.ejphar.2015.04.056", "PMC4784719", "25987420"]}, {"Citation": "Stuhldreier F., Schmitt L., Lenz T., Hinxlage I., Zimmermann M., Wollnitzke P., Schliehe-Diecks J., Liu Y., J\u00e4ger P., Geyh S., et al. The Mycotoxin Viriditoxin Induces Leukemia- and Lymphoma-Specific Apoptosis by Targeting Mitochondrial Metabolism. Cell Death Dis. 2022;13:938. doi: 10.1038/s41419-022-05356-w.", "ArticleIdList": ["10.1038/s41419-022-05356-w", "PMC9643474", "36347842"]}, {"Citation": "Yin X., Li Z., Lyu C., Wang Y., Ding S., Ma C., Wang J., Cui S., Wang J., Guo D., et al. Induced Effect of Zinc Oxide Nanoparticles on Human Acute Myeloid Leukemia Cell Apoptosis by Regulating Mitochondrial Division. IUBMB Life. 2022;74:519\u2013531. doi: 10.1002/iub.2615.", "ArticleIdList": ["10.1002/iub.2615", "35383422"]}, {"Citation": "Westermann B. Mitochondrial Fusion and Fission in Cell Life and Death. Nat. Rev. Mol. Cell Biol. 2010;11:872\u2013884. doi: 10.1038/nrm3013.", "ArticleIdList": ["10.1038/nrm3013", "21102612"]}, {"Citation": "Dehkordi M.H., Munn R.G.K., Fearnhead H.O. Non-Canonical Roles of Apoptotic Caspases in the Nervous System. Front. Cell Dev. Biol. 2022;10:840023. doi: 10.3389/fcell.2022.840023.", "ArticleIdList": ["10.3389/fcell.2022.840023", "PMC8904960", "35281082"]}, {"Citation": "Boice A., Bouchier-Hayes L. Targeting Apoptotic Caspases in Cancer. Biochim. Biophys. Acta Mol. Cell Res. 2020;1867:118688. doi: 10.1016/j.bbamcr.2020.118688.", "ArticleIdList": ["10.1016/j.bbamcr.2020.118688", "PMC7155770", "32087180"]}, {"Citation": "Lamkanfi M. Alice in Caspase Land. A Phylogenetic Analysis of Caspases from Worm to Man. Cell Death Differ. 2002;9:358\u2013361. doi: 10.1038/sj.cdd.4400989.", "ArticleIdList": ["10.1038/sj.cdd.4400989", "11965488"]}, {"Citation": "Van Opdenbosch N., Lamkanfi M. Caspases in Cell Death, Inflammation, and Disease. Immunity. 2019;50:1352\u20131364. doi: 10.1016/j.immuni.2019.05.020.", "ArticleIdList": ["10.1016/j.immuni.2019.05.020", "PMC6611727", "31216460"]}, {"Citation": "Thornberry N.A., Lazebnik Y. Caspases: Enemies Within. Science. 1998;281:1312\u20131316. doi: 10.1126/science.281.5381.1312.", "ArticleIdList": ["10.1126/science.281.5381.1312", "9721091"]}, {"Citation": "Peyssonnaux C., Provot S., Felder-Schmittbuhl M.P., Calothy G., Eych\u00e8ne A. Induction of Postmitotic Neuroretina Cell Proliferation by Distinct Ras Downstream Signaling Pathways. Mol. Cell. Biol. 2000;20:7068\u20137079. doi: 10.1128/MCB.20.19.7068-7079.2000.", "ArticleIdList": ["10.1128/MCB.20.19.7068-7079.2000", "PMC86245", "10982823"]}, {"Citation": "Chang F., Steelman L.S., Lee J.T., Shelton J.G., Navolanic P.M., Blalock W.L., Franklin R.A., McCubrey J.A. Signal Transduction Mediated by the Ras/Raf/MEK/ERK Pathway from Cytokine Receptors to Transcription Factors: Potential Targeting for Therapeutic Intervention. Leukemia. 2003;17:1263\u20131293. doi: 10.1038/sj.leu.2402945.", "ArticleIdList": ["10.1038/sj.leu.2402945", "12835716"]}, {"Citation": "Yan J., Roy S., Apolloni A., Lane A., Hancock J.F. Ras Isoforms Vary in Their Ability to Activate Raf-1 and Phosphoinositide 3-Kinase. J. Biol. Chem. 1998;273:24052\u201324056. doi: 10.1074/jbc.273.37.24052.", "ArticleIdList": ["10.1074/jbc.273.37.24052", "9727023"]}, {"Citation": "Chang F., Steelman L.S., Shelton J.G., Lee J.T., Navolanic P.M., Blalock W.L., Franklin R., McCUBREY J.A. Regulation of Cell Cycle Progression and Apoptosis by the Ras/Raf/MEK/ERK Pathway (Review) Int. J. Oncol. 2003;22:469\u2013480. doi: 10.3892/ijo.22.3.469.", "ArticleIdList": ["10.3892/ijo.22.3.469", "12579299"]}, {"Citation": "Steelman L.S., Pohnert S.C., Shelton J.G., Franklin R.A., Bertrand F.E., McCubrey J.A. JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in Cell Cycle Progression and Leukemogenesis. Leukemia. 2004;18:189\u2013218. doi: 10.1038/sj.leu.2403241.", "ArticleIdList": ["10.1038/sj.leu.2403241", "14737178"]}, {"Citation": "Mizutani S., Inouye K., Koide H., Kaziro Y. Involvement of B-Raf in Ras-Induced Raf-1 Activation. FEBS Lett. 2001;507:295\u2013298. doi: 10.1016/S0014-5793(01)02992-1.", "ArticleIdList": ["10.1016/S0014-5793(01)02992-1", "11696358"]}, {"Citation": "Rapp U., Goldsborough M., Mark G., Bonner T., Groffen J., Reynolds F. Structure and Biological Activity of V-Raf, a Unique Oncogene Transduced by a Retrovirus. Proc. Natl. Acad. Sci. USA. 1983;80:4218\u20134222. doi: 10.1073/pnas.80.14.4218.", "ArticleIdList": ["10.1073/pnas.80.14.4218", "PMC384008", "6308607"]}, {"Citation": "Zuo Z., Liu J., Sun Z., Cheng Y.-W., Ewing M., Bugge T.H., Finkel T., Leppla S.H., Liu S. ERK and C-Myc Signaling in Host-Derived Tumor Endothelial Cells Is Essential for Solid Tumor Growth. Proc. Natl. Acad. Sci. USA. 2023;120:e2211927120. doi: 10.1073/pnas.2211927120.", "ArticleIdList": ["10.1073/pnas.2211927120", "PMC9910475", "36574698"]}, {"Citation": "Yada M., Hatakeyama S., Kamura T., Nishiyama M., Tsunematsu R., Imaki H., Ishida N., Okumura F., Nakayama K., Nakayama K.I. Phosphorylation-Dependent Degradation of c-Myc Is Mediated by the F-Box Protein Fbw7. EMBO J. 2004;23:2116\u20132125. doi: 10.1038/sj.emboj.7600217.", "ArticleIdList": ["10.1038/sj.emboj.7600217", "PMC424394", "15103331"]}, {"Citation": "Welcker M., Orian A., Jin J., Grim J.A., Harper J.W., Eisenman R.N., Clurman B.E. The Fbw7 Tumor Suppressor Regulates Glycogen Synthase Kinase 3 Phosphorylation-Dependent c-Myc Protein Degradation. Proc. Natl. Acad. Sci. USA. 2004;101:9085\u20139090. doi: 10.1073/pnas.0402770101.", "ArticleIdList": ["10.1073/pnas.0402770101", "PMC428477", "15150404"]}, {"Citation": "Johnson D.E., O\u2019Keefe R.A., Grandis J.R. Targeting the IL-6/JAK/STAT3 Signalling Axis in Cancer. Nat. Rev. Clin. Oncol. 2018;15:234\u2013248. doi: 10.1038/nrclinonc.2018.8.", "ArticleIdList": ["10.1038/nrclinonc.2018.8", "PMC5858971", "29405201"]}, {"Citation": "Ning R., Chen G., Fang R., Zhang Y., Zhao W., Qian F. Diosmetin Inhibits Cell Proliferation and Promotes Apoptosis through STAT3/c-Myc Signaling Pathway in Human Osteosarcoma Cells. Biol. Res. 2021;54:40. doi: 10.1186/s40659-021-00363-1.", "ArticleIdList": ["10.1186/s40659-021-00363-1", "PMC8684101", "34922636"]}, {"Citation": "Sun J., Du Y., Song Q., Nan J., Guan P., Guo J., Wang X., Yang J., Zhao C. E2F Is Required for STAT3-Mediated Upregulation of Cyclin B1 and Cdc2 Expressions and Contributes to G2\u2013M Phase Transition. Acta Biochim. Biophys. Sin. 2019;51:313\u2013322. doi: 10.1093/abbs/gmy174.", "ArticleIdList": ["10.1093/abbs/gmy174", "30726872"]}, {"Citation": "Ma L., Zhang J., Wang X., Yang J., Guo L., Wang X., Song B., Dong W., Wang W. Design and Synthesis of Diosgenin Derivatives as Apoptosis Inducers through Mitochondria-Related Pathways. Eur. J. Med. Chem. 2021;217:113361. doi: 10.1016/j.ejmech.2021.113361.", "ArticleIdList": ["10.1016/j.ejmech.2021.113361", "33740546"]}]}], "History": [{"Year": "2023", "Month": "12", "Day": "27"}, {"Year": "2024", "Month": "3", "Day": "17"}, {"Year": "2024", "Month": "3", "Day": "19"}, {"Year": "2024", "Month": "4", "Day": "15", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "4", "Day": "13", "Hour": "10", "Minute": "43"}, {"Year": "2024", "Month": "4", "Day": "13", "Hour": "1", "Minute": "10"}, {"Year": "2024", "Month": "4", "Day": "3"}], "PublicationStatus": "epublish", "ArticleIdList": ["38611876", "PMC11013136", "10.3390/molecules29071597", "molecules29071597"]}}]}